341 related articles for article (PubMed ID: 24125877)
1. Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines.
Monteiro AS; Almeida J; Cabral G; Severino P; Videira PA; Sousa A; Nunes R; Pereira JD; Francisco AP; Perry MJ; Mendes E
Eur J Med Chem; 2013; 70():1-9. PubMed ID: 24125877
[TBL] [Abstract][Full Text] [Related]
2. Dopamine- and tyramine-based derivatives of triazenes: activation by tyrosinase and implications for prodrug design.
Perry MJ; Mendes E; Simplício AL; Coelho A; Soares RV; Iley J; Moreira R; Francisco AP
Eur J Med Chem; 2009 Aug; 44(8):3228-34. PubMed ID: 19386398
[TBL] [Abstract][Full Text] [Related]
3. The selective cytotoxicity of new triazene compounds to human melanoma cells.
Sousa A; Santos F; Gaspar MM; Calado S; Pereira JD; Mendes E; Francisco AP; Perry MJ
Bioorg Med Chem; 2017 Aug; 25(15):3900-3910. PubMed ID: 28602669
[TBL] [Abstract][Full Text] [Related]
4. New prodrugs derived from 6-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT).
Knaggs S; Malkin H; Osborn HM; Williams NA; Yaqoob P
Org Biomol Chem; 2005 Nov; 3(21):4002-10. PubMed ID: 16240021
[TBL] [Abstract][Full Text] [Related]
5. Indirect oxidation of the antitumor agent procarbazine by tyrosinase--possible application in designing anti-melanoma prodrugs.
Gasowska-Bajger B; Wojtasek H
Bioorg Med Chem Lett; 2008 Jun; 18(11):3296-300. PubMed ID: 18457951
[TBL] [Abstract][Full Text] [Related]
6. Towards an efficient prodrug of the alkylating metabolite monomethyltriazene: synthesis and stability of N-acylamino acid derivatives of triazenes.
Perry Mde J; Carvalho E; Rosa E; Iley J
Eur J Med Chem; 2009 Mar; 44(3):1049-56. PubMed ID: 18687506
[TBL] [Abstract][Full Text] [Related]
7. Melanocyte-Directed enzyme prodrug therapy (MDEPT): development of second generation prodrugs for targeted treatment of malignant melanoma.
Jordan AM; Khan TH; Malkin H; Osborn HM; Photiou A; Riley PA
Bioorg Med Chem; 2001 Jun; 9(6):1549-58. PubMed ID: 11408174
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, computational studies, tyrosinase inhibitory kinetics and antimelanogenic activity of hydroxy substituted 2-[(4-acetylphenyl)amino]-2-oxoethyl derivatives.
Rafiq M; Nazir Y; Ashraf Z; Rafique H; Afzal S; Mumtaz A; Hassan M; Ali A; Afzal K; Yousuf MR; Saleem M; Kotwica-Mojzych K; Mojzych M
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1-11. PubMed ID: 31456445
[TBL] [Abstract][Full Text] [Related]
9. Triazene drug metabolites. Part 17: Synthesis and plasma hydrolysis of acyloxymethyl carbamate derivatives of antitumour triazenes.
Carvalho E; Francisco AP; Iley J; Rosa E
Bioorg Med Chem; 2000 Jul; 8(7):1719-25. PubMed ID: 10976519
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of carbidopa by tyrosinase and its effect on murine melanoma.
Gasowska-Bajger B; Frackowiak-Wojtasek B; Koj S; Cichoń T; Smolarczyk R; Szala S; Wojtasek H
Bioorg Med Chem Lett; 2009 Jul; 19(13):3507-10. PubMed ID: 19457668
[TBL] [Abstract][Full Text] [Related]
11. Melanocyte-directed enzyme prodrug therapy (MDEPT): development of a targeted treatment for malignant melanoma.
Jordan AM; Khan TH; Osborn HM; Photiou A; Riley PA
Bioorg Med Chem; 1999 Sep; 7(9):1775-80. PubMed ID: 10530924
[TBL] [Abstract][Full Text] [Related]
12. Targeting gliomas with triazene-based hybrids: Structure-activity relationship, mechanistic study and stability.
Braga C; Vaz AR; Oliveira MC; Matilde Marques M; Moreira R; Brites D; Perry MJ
Eur J Med Chem; 2019 Jun; 172():16-25. PubMed ID: 30939350
[TBL] [Abstract][Full Text] [Related]
13. Modulating effect of new potential antimelanomic agents, spin-labeled triazenes and nitrosoureas on the DOPA-oxidase activity of tyrosinase.
Gadjeva V; Zheleva A; Raikova E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):99-108. PubMed ID: 10738906
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a prodrug designed to release multiple inhibitors of the epidermal growth factor receptor tyrosine kinase and an alkylating agent: a novel tumor targeting concept.
Banerjee R; Rachid Z; McNamee J; Jean-Claude BJ
J Med Chem; 2003 Dec; 46(25):5546-51. PubMed ID: 14640561
[TBL] [Abstract][Full Text] [Related]
15. A new cyclopamine glucuronide prodrug with improved kinetics of drug release.
Renoux B; Legigan T; Bensalma S; Chadéneau C; Muller JM; Papot S
Org Biomol Chem; 2011 Dec; 9(24):8459-64. PubMed ID: 22042246
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and one-electron reduction characteristics of radiation-activated prodrugs possessing two 5-fluorodeoxyuridine units.
Tanabe K; Sugiura M; Ito T; Nishimoto S
Bioorg Med Chem; 2012 Sep; 20(17):5164-8. PubMed ID: 22847019
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and SAR of 2',3'-bis-O-substituted N(6), 5'-bis-ureidoadenosine derivatives: implications for prodrug delivery and mechanism of action.
Shelton JR; Cutler CE; Browning MS; Balzarini J; Peterson MA
Bioorg Med Chem Lett; 2012 Oct; 22(19):6067-71. PubMed ID: 22959517
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 4-nitro-substituted 1,3-diaryltriazenes as a novel class of potent antitumor agents.
Cimbora-Zovko T; Brozovic A; Piantanida I; Fritz G; Virag A; Alič B; Majce V; Kočevar M; Polanc S; Osmak M
Eur J Med Chem; 2011 Jul; 46(7):2971-83. PubMed ID: 21550697
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
Gili A; Thomas PD; Ota M; Jimbow K
Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative activity of triazenoindazoles and triazenopyrazoles: a comparative study.
Daidone G; Raffa D; Maggio B; Valeria Raimondi M; Plescia F; Schillaci D
Eur J Med Chem; 2004 Mar; 39(3):219-24. PubMed ID: 15051169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
